Huntington Bancshares Incorporated (HBAN) Stock Analysis
Is HBAN a good investment?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 63.0/100 as of November 13, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: P/B of 1.08x provides TBV floor (~$14.57/share) — downside is structurally capped near book value for a solvent bank; D/E of 0.54 (45.4% below peer average of 0.989) and $18.24B cash make insolvency risk negligible; FCF of $2.92B funds capital return without stress. Main concern: Three consecutive quarters of YoY EPS decline (Q3 2026: $0.38 vs $0.40, -5%) — the EPS recovery thesis at 32.6% forward growth has not begun to show in actual reported numbers; each passing quarter of continued decline erodes credibility of the inflection and creates downside risk to analyst targets; analyst target has fallen cumulatively from $20.12 to $19.00 (-5.6%) over ~42 days.
Investment Summary
HBAN at $15.73 represents a modestly undervalued regional bank with a P/B of 1.08x (near tangible book value ~$14.57), P/E of 12.85x, and PEG of 1.06 — all in-line to slightly cheap versus peers. The core thesis rests on a 32.6% next-year EPS recovery materializing after three consecutive quarters of YoY EPS decline (Q3 2026: $0.38 vs $0.40, -5%). The analyst consensus target of $19.00 implies +20.8% upside. However, the stock has pulled back -1.5% from the prior entry midpoint of $15.97, now sitting at $15.73 — finally approaching the top of the prior entry zone ($14.80-$15.50). Two key concerns remain: (1) EPS compression is unresolved — the market is pricing a recovery that has not yet appeared in reported numbers; (2) ROE of 9.15% remains 23.2% below the peer average of 11.92%, a structural drag. The stress test clearance (Fed) is a genuine positive, confirming capital adequacy. The frozen dividend since late 2021 signals cautious capital allocation. Net-net: the stock is now modestly more attractive at $15.73 vs $15.97 two weeks ago, but the EPS inflection thesis still requires proof.
Key Strengths
- P/B of 1.08x provides TBV floor (~$14.57/share) — downside is structurally capped near book value for a solvent bank; D/E of 0.54 (45.4% below peer average of 0.989) and $18.24B cash make insolvency risk negligible; FCF of $2.92B funds capital return without stress
- Next-year forward EPS growth of 32.6% is +82.7% above the industry average of 17.85% — if credit normalization materializes, forward P/E drops to approximately 8-9x at current price, deeply cheap for any profitable franchise; Fed stress test clearance confirms capital base can support this recovery
- Operating margin of 40.46% (+8.4% above peers) and net margin of 15.25% (+10.1% above peers) demonstrate genuine below-peer cost structure advantages and revenue efficiency that persist through the earnings compression cycle
Key Concerns
- Three consecutive quarters of YoY EPS decline (Q3 2026: $0.38 vs $0.40, -5%) — the EPS recovery thesis at 32.6% forward growth has not begun to show in actual reported numbers; each passing quarter of continued decline erodes credibility of the inflection and creates downside risk to analyst targets; analyst target has fallen cumulatively from $20.12 to $19.00 (-5.6%) over ~42 days
- ROE of 9.15% is structurally 23.2% below the peer average of 11.92% with no improvement signal — combined with the frozen dividend (unchanged since late 2021), this raises questions about whether HBAN can generate adequate returns on shareholder capital or deploy its conservative capital base more productively
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
HBAN's fundamentals reflect a bank in transition. Valuation anchors are compelling: P/E of 12.85x (vs. industry 12.39x, only +3.7% premium), P/B of 1.08x (near TBV floor of ~$14.57/share), PEG of 1.06 (vs. industry 1.062, essentially at-par), and FCF of $2.92B supporting the balance sheet. Operating margin of 40.46% beats peers by +8.4% and net margin of 15.25% exceeds peers by +10.1%, confirming genuine efficiency advantages. However, the gap between operating margin (40.5%) and net margin (15.2%) — a 25pp spread — signals heavy provisioning or non-operating costs. ROE of 9.15% is 23.2% below the peer average of 11.92%, the most persistent structural weakness. Historical EPS growth of -19.5% vs. peer average of +25.25% (a catastrophic -44.75pp gap) versus forward EPS growth of +32.6% (vs. peer 17.85%, a +82.7% premium) captures the entire debate: backward-looking HBAN is a laggard; forward-looking HBAN is a leader — if you believe the recovery. D/E of 0.54 vs. peer 0.989 (45.4% lower leverage) is a double-edged sword: balance sheet safety but structurally depressed ROE. Cash of $18.24B and FCF of $2.92B confirm no near-term solvency or liquidity risk.
News Sentiment
Huntington Bancshares is navigating a critical moment as investors wait for the regional bank's long-promised earnings recovery to actually show up in the numbers. The good news first: Huntington cleared the Federal Reserve's annual stress tests, demonstrating the bank has sufficient capital to weather severe economic downturns — a meaningful confidence booster that removes one tail risk from the investment thesis. On the innovation front, 'Huntington Bank Announces Treasury Solution that Turns Multi-Bank Complexity' into a simplified platform, a move that could strengthen commercial banking relationships and improve client retention in an increasingly competitive landscape for corporate deposits. The bank's Q3 earnings came in meeting estimates — headlines like 'Huntington Bancshares (HBAN) Meets Q3 Earnings Estimates' and multiple preview articles ('Huntington Q3 Earnings on Deck: Here's What Investors Should Expect') generated significant analyst attention — but 'meeting estimates' masks the concerning trend: Q3 EPS of $0.38 was still below last year's $0.40, extending the streak of year-over-year earnings declines. The frozen quarterly dividend, unchanged since late 2021, tells a story of a management team playing it cautiously — potentially wise given the credit environment, but frustrating for income investors. The bank does yield approximately $4,478 annually per $120,000 invested, making it a modest income play. The bottom line: Huntington is operationally solid, well-capitalized, and setting up for what analysts expect will be a sharp 2026 earnings rebound — but that rebound hasn't started yet.
Risk Assessment
PRIMARY RISK: The 32.6% forward EPS recovery is the entire bull case — if Q4 2026 and Q1 2027 earnings continue the -5% YoY pattern, forward estimates will be cut, PEG will expand above 1.3-1.4x, and the stock could re-rate toward $13.50-$14.00 (book value). SECONDARY RISK: Analyst target erosion has been consistent (-5.6% in 42 days) — a further cut to $17-$18 would change the risk/reward math materially. MITIGATION: TBV of ~$14.57 provides a natural floor — book-value buyers historically prevent solvent banks from trading significantly below tangible book. Stop at $13.75 is 5.6% below TBV, a level that would only be breached in a genuine credit quality deterioration scenario. The Fed stress test clearance reduces tail risk. Position size of 2.0% limits portfolio damage if thesis fails. MACRO RISK: Rate environment changes could compress NIM further, extending the earnings compression cycle beyond current estimates.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is HBAN a halal stock?
No, Huntington Bancshares Incorporated (HBAN) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for HBAN?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 63.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is HBAN a good investment?
According to Plutrex AI, HBAN has a Hold rating (63.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in HBAN?
US stocks like HBAN can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in HBAN?
Plutrex AI identifies the main risks for HBAN by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.